Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: east who wrote (6006)	3/20/1998 8:53:00 AM
From: BigKNY3	Respond to of 23519

East:.For those VVUSers who want to know the facts, it is worthwhile to know the record of the brokers who follow the stock and their previous involvement with the company (previous recommendations and/or involvement in stock offerings?). Here is what Genesis had to say on 10/28/97 with VVUS @24 13/16 and on 12/10/97 with VVUS @13 13/16. Good investing! BigKNY3 Vivus @ 24 13/16 Genesis Reiterates Strong Buy on Vivus; Analyst Continues $75 Price Target PR Newswire, Tuesday, October 28, 1997 at 13:56 SAN FRANCISCO, Oct. 28 /PRNewswire/ -- Genesis Merchant Group Securities reiterated its strong buy rating on Vivus, Inc. (NASDAQ:VVUS) and continued its $75 per share price target. According to associate analyst Curtis Hogue, production capacity remains at or above third quarter levels, and Vivus continues to sell all the product produced at its New Jersey facility. SOURCE Genesis Merchant Group Securities -0- 10/28/97 /CONTACT: Analyst, Curtis Hogue of Genesis Merchant Group Securities, 415-677-1500/ /Web site: sternco.com / ________________________________________________ Vivus@13 13/16 12/10/97 Downgrades: Genesis downgraded Vivus from Strong Buy to Buy